ImmuCell Corporation ICCC-Financial and Strategic SWOT Analysis Review

ImmuCell Corporation ICCC-Financial and Strategic SWOT Analysis Review

  • Products Id :- GDME317FSA
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

ImmuCell Corporation (ICCC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


ImmuCell Corporation (Immucell) is an animal health biotechnology company. It develops, manufactures and markets products that improve animal health and productivity in the dairy and beef industries. The company focuses on the prevention, diagnosis and treatment of bovine diseases. The company's major products include First Defense bovine coronavirus-escherichia coli antibody; Wipe Out dairy wipes; and California Mastitis Test (CMT). Immucell is also developing Mast Out, an intramammary infusion product for the treatment of subclinical mastitis in lactating dairy cows. The company has developed its products based on the requirement in two areas, namely, Intelligent Mastitis Management and Calf Health. The company sells its products through distributors and dairy producers. ImmuCell is headquartered in Maine, the US.

ImmuCell Corporation Key Recent Developments

May 11, 2016: ImmuCell Announces First Quarter 2016 Financial Results

Feb 10, 2016: ImmuCell Announces Full Year 2015 Financial Results

Jan 28, 2016: ImmuCell Announces Proposed Public Offering of Common Stock and Preliminary Full Year 2015 Results

Nov 12, 2015: ImmuCell Announces Results for Third Quarter of 2015

Aug 13, 2015: ImmuCell Announces Results for Second Quarter of 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

ImmuCell Corporation-Key Facts 6

ImmuCell Corporation-Key Employees 7

ImmuCell Corporation-Key Employee Biographies 8

ImmuCell Corporation-Key Operational Employees 9

ImmuCell Corporation-Major Products and Services 10

ImmuCell Corporation-History 11

ImmuCell Corporation-Locations And Subsidiaries 13

Head Office 13

Section 2-Company Analysis 14

ImmuCell Corporation-Business Description 14

ImmuCell Corporation-Corporate Strategy 15

ImmuCell Corporation-SWOT Analysis 16

SWOT Analysis-Overview 16

ImmuCell Corporation-Strengths 16

Strength-Flagship Product First Defense 16

Strength-Distribution Network 16

Strength-Robust Technical and Corporate Expertise 16

ImmuCell Corporation-Weaknesses 17

Weakness-Dependence on Single Product 17

ImmuCell Corporation-Opportunities 18

Opportunity-Growth Potential: Mastitis 18

Opportunity-Veterinary Market 18

Opportunity-Strategic Initiatives 18

ImmuCell Corporation-Threats 19

Threat-Stiff Competition 19

Threat-Bovine Diseases 19

Threat-Stringent Regulations 19

ImmuCell Corporation-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 28

ImmuCell Corporation, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

Nov 12, 2015: ImmuCell Announces Results for Third Quarter of 2015 30

Aug 13, 2015: ImmuCell Announces Results for Second Quarter of 2015 32

May 12, 2015: ImmuCell Announces Results for First Quarter of 2015 34

Section 6-Appendix 36

Methodology 36

Ratio Definitions 36

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

ImmuCell Corporation, Performance Chart (2011-2015) 24

ImmuCell Corporation, Ratio Charts 26

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 28

List of Tables

ImmuCell Corporation, Key Facts 6

ImmuCell Corporation, Key Employees 7

ImmuCell Corporation, Key Employee Biographies 8

ImmuCell Corporation, Key Operational Employees 9

ImmuCell Corporation, Major Products and Services 10

ImmuCell Corporation, History 11

ImmuCell Corporation, Key Competitors 20

ImmuCell Corporation, Ratios based on current share price 21

ImmuCell Corporation, Annual Ratios 22

ImmuCell Corporation, Interim Ratios 25

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 28

ImmuCell Corporation, Recent Deals Summary 29

Currency Codes 36

Capital Market Ratios 36

Equity Ratios 37

Profitability Ratios 37

Cost Ratios 38

Liquidity Ratios 38

Leverage Ratios 39

Efficiency Ratios 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Zoetis Inc.

MSD Animal Health Nederland

Idexx Laboratories, Inc.

Elanco Animal Health, Inc.

Boehringer Ingelheim Animal Health Gmbh

ImmuCell Corporation, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 7990
Site License
USD 250 INR 15980
Corporate User License
USD 375 INR 23970



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]